TXN and acute lymphoblastic leukemia: Collectively, our results highlight an important, pro‐survival role of the TXN system antioxidant enzymes in BCP‐ALL cells and the efficacy of their inhibitors, mainly AUR, as potential, novel drugs against BCP‐ALL.